RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia

被引：5
|
作者：
Chow, Signy [1 ]
Tang, Kenny [2 ]
Al-Abri, Mahmood [2 ]
Hall, Victoria [3 ]
Tremblay-Lemay, Rosemarie [4 ,5 ]
Rashedi, Iran [6 ]
Tsui, Hubert [7 ,8 ]
Chan, Steven M. [9 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[3] Univ Hlth Network, Transplant Infect Dis & Ajmera Transplant Ctr, Toronto, ON, Canada
[4] Toronto Gen Hosp, Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Hematol Pathol, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[8] Sunnybrook Hlth Sci Ctr, Div Hematol Pathol, Dept Lab Med & Mol Diagnost, Toronto, ON, Canada
[9] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
来源：
LEUKEMIA RESEARCH | 2021年 / 111卷
关键词：
D O I：
10.1016/j.leukres.2021.106735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia
    Wille, Kai
    Dumke, Marvin
    Wilsdorf, Nadine
    Sadjadian, Parvis
    Schneider, Artur
    Jender-Bartling, Stephanie
    Kolatzki, Vera
    Horstmann, Anette
    Meixner, Raphael
    Jimenez-Munoz, Marina
    Fuchs, Christiane
    Tischler, Hans-Joachim
    Griesshammer, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 17 - 25
  • [32] Searching for germline mutations in the RUNX1 gene among Polish patients with acute myeloid leukemia
    Bak, Aneta
    Skonieczka, Katarzyna
    Jaskowiec, Anna
    Junkiert-Czarnecka, Anna
    Heise, Marta
    Pilarska-Deltow, Maria
    Potoczek, Stanislaw
    Czyzewska, Maria
    Haus, Olga
    LEUKEMIA & LYMPHOMA, 2021, 62 (07) : 1749 - 1755
  • [33] Frequency and Clinicopathologic Features of RUNX1 Mutations in Patients With Acute Myeloid Leukemia Not Otherwise Specified
    You, Eunkyoung
    Cho, Young-Uk
    Jang, Seongsoo
    Seo, Eul-Ju
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Koh, Kyung-Nam
    Im, Ho Joon
    Seo, Jong Jin
    Park, Young-Mi
    Lee, Jong-Keuk
    Park, Chan-Jeoung
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (01) : 64 - 72
  • [34] Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
    Weng, Guangyang
    Zhang, Yu
    Yu, Guopan
    Luo, Tingyue
    Yu, Sijian
    Xu, Na
    Sun, Zhiqiang
    Lin, Dongjun
    Deng, Lan
    Liang, Xinquan
    Xiao, Jie
    Zhang, Hongyu
    Guo, Ziwen
    Shao, Ruoyang
    Du, Xin
    Jin, Hua
    Liu, Qifa
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (03) : 329 - 339
  • [35] VENETOCLAX IN COMBINATION AS A TREATMENT OF ACUTE MYELOID LEUKEMIA IN RECALLED OR REFRACTORY PATIENTS
    Hernandez Jasson, Villarreal
    Esteve Maria, Condom
    Marin Helena, Pomares
    Polo Susana, Vives
    Jorda Rosa, Coll
    Calvo Marta, Cervera
    Artigal Clara, Maluquer
    Fernandez Gladys, Ibarra
    Albert, Torrent
    Barajas Mercedes, Galiano
    Balari Anna, Sureda
    Sangerman Montserrat, Arnan
    HAEMATOLOGICA, 2021, 106 (10) : 215 - 215
  • [36] TdT plus Acute Myeloid Leukemia is enriched for mutations of RUNX1, BCOR, and ASXL1
    Bailey, Nathanael
    Carlsen, Eric
    Wild, Matthew
    Liu, Yen-Chun
    Djokic, Miroslav
    LABORATORY INVESTIGATION, 2019, 99
  • [37] Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia
    Weng, Guangyang
    Zhang, Yu
    Yu, Guopan
    Xu, Na
    Sun, Zhiqiang
    Lin, Dongjun
    Liang, Xinquan
    Deng, Lan
    Xiao, Jie
    Zhang, Hongyu
    Guo, Ziwen
    Jin, Hua
    Du, Xin
    Liu, Qifa
    BLOOD, 2022, 140 : 2025 - 2026
  • [38] Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience
    Secilmis, Sema
    Bozan, Ersin
    Darcin, Tahir
    Yaman, Samet
    Yigenoglu, Tugcenur
    Ulu, Bahar Uncu
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Yildiz, Jale
    Baysal, Nuran Ahu
    Iskender, Dicle
    Cakar, Merih Kizil
    Sinan, Dal Mehmet
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S192 - S193
  • [39] Results of a Phase 1 Trial Testing the Novel Combination Therapy of Venetoclax and Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia Patients
    Borate, Uma M.
    Madanat, Yazan F.
    Tognon, Cristina
    Mishra, Shikha
    Kaempf, Andy
    Patel, Prapti A.
    Kurtz, Stephen E.
    Johnson, Kara
    Vasu, Sumithira
    Baker, Sharyn D.
    Robinson, Bridget A.
    Vu, Tania Q.
    Eide, Christopher A.
    Minnier, Jessica
    Zhang, Yiqing
    Clement, Peter
    Avaylon, Sammantha
    Jacob, Thomas
    Cook, Rachel
    Gandhi, Arpita
    Leonard, Jessica T.
    Hayes-Lattin, Brandon
    Newell, Laura F.
    Maziarz, Richard T.
    Traer, Elie
    Swords, Ronan T.
    Tyner, Jeffrey W.
    Druker, Brian J.
    Saultz, Jennifer N.
    BLOOD, 2023, 142
  • [40] Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
    Zha, Jie
    Zhou, Hui
    Zhong, Mengya
    Wang, Ying
    Du, Xin
    Gong, Tiejun
    Lin, Zhijuan
    Cai, Yun
    Xie, Siting
    Xie, Chendi
    Feng, XianQi
    Huang, ZhenQi
    Su, Liping
    Luo, Jianmin
    Yang, Lin
    Li, Zhenling
    Chen, Bi-yun
    Xie, Ying
    Zhu, Yu
    Shi, Pengcheng
    Li, Zhifeng
    Jiang, Yirong
    Xu, Bing
    BLOOD, 2022, 140 : 3292 - 3293
12345